Kaneka Medical America, LLC
The LIPOSORBER® LA-15 System is indicated for use in the treatment of adult and
pediatric patients with nephrotic syndrome associated with primary focal segmental
glomerulosclerosis (FSGS) when:
• standard treatment options, including corticosteroids and/or calcineurin inhibitor,
treatments are unsuccessful or not well tolerated and the patient’s glomerular filtration
rate (GFR) ≥ 60 ml/min/1.73 m2
or
• The patient is post renal transplantation.
Additional Info
First-time Exhibitor:
Yes